Subgroups | No. of included studiesa | Summarized prevalence of active TBb (95% CI) | Heterogeneity | |
I2 | P for Q test | |||
Total | 18 | 2.68% (2.02%-3.35%) | 95.67% |  < 0.0001 |
From high TB burden countriese | 4 | 5.55% (2.98%-8.11%) | 85.90% |  < 0.0001 |
From other countriese | 14 | 2.16% (1.49%-2.82%) | 95.89% |  < 0.0001 |
Subgroups | No. of included studiesc | Summarized prevalence of MTB infection (95% CI) | Heterogeneity | |
I2 | P for Q test | |||
Total | 20 | 46.30% (37.18%-55.41%)d | 99.58% |  < 0.0001 |
Testing by TST | 18 | 48.37% (38.58%-58.16%) | 99.61% |  < 0.0001 |
Testing by IGRA | 6 | 41.24% (21.06%-61.42%) | 99.67% |  < 0.0001 |
Index cases were smear +  | 5 | 53.94% (41.76%-66.12%) | 98.90% |  < 0.0001 |
From high TB burden countriese | 6 | 52.80% (38.62%-66.98%) | 98.99% |  < 0.0001 |
From other countriese | 14 | 43.51% (32.32%-54.71%) | 99.65% |  < 0.0001 |